Vicore Pharma Holding
Vicore Pharma: FPI Covid-19 (Redeye)

2020-07-28 07:15
Redeye reiterates its positive stance towards Vicore following the announcement of first Covid-19 patient being dosed in its phase II trial. We currently regard the Covid-19 indication as a bonus in our Base case, with considerable scope for re-valuation if results are proven encouraging. We expect top-line results from the trial already later this year.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Vicore Pharma Holding - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -